US Map / Oklahoma
State OK

Clinical Trials in Oklahoma

Oklahoma is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Oklahoma and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 110 actively recruiting studies with Oklahoma sites out of 110 registered in total. The busiest research areas in Oklahoma are Ovarian Cancer, Endometrial Cancer, Fallopian Tube Cancer. Leading sponsors running trials in the state include University of Oklahoma, National Cancer Institute (NCI), AstraZeneca. By stage, Oklahoma trials break down as Phase 1 (16), Phase 2 (40), Phase 3 (45), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
110
Recruiting Now
110
← Back to US Map
Top Conditions in Oklahoma
Ovarian Cancer (4)Endometrial Cancer (4)Fallopian Tube Cancer (3)Obesity (3)Overweight (3)Solid Tumor (2)Anatomic Stage IV Breast Cancer AJCC v8 (2)Hypertension (2)Colitis, Ulcerative (2)Primary Peritoneal Cancer (2)Intracranial Meningioma (2)High Grade Serous Ovarian Cancer (2)

Frequently Asked Questions — Clinical Trials in Oklahoma

How many clinical trials are currently recruiting in Oklahoma?
ClinicalMetric currently tracks 110 actively recruiting clinical trials with at least one location in Oklahoma. The total number of registered studies—including active but not currently enrolling trials—is 110. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Oklahoma?
Oklahoma hosts clinical trials across a broad range of medical conditions, including Ovarian Cancer, Endometrial Cancer, Fallopian Tube Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Oklahoma serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Oklahoma?
To join a clinical trial in Oklahoma, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Oklahoma maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Oklahoma

NCT07811726 Phase 2
Recruiting
The Purpose of This Study is to Evaluate Efficacy and Safety of NT-101 Eye Drops...
Condition
Wet Age Related Macular Degeneration
Enrollment
66 pts
Location
United States
Sponsor
NexThera Co., Ltd.
View Trial →
NCT07166289 N/A
Recruiting
Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment...
Condition
Treatment-Resistant Depression
Enrollment
140 pts
Location
United States
Sponsor
Laureate Institute for Brain R
View Trial →
NCT07361510 Phase 3
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participan...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06241456 Phase 1
Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibod...
Condition
Advanced Solid Tumor
Enrollment
351 pts
Location
United States
Sponsor
Fate Therapeutics
View Trial →
NCT06072781 Phase 3
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade ...
Condition
Low Grade Serous Ovarian Cancer
Enrollment
270 pts
Location
United States, Australia, Belgium
Sponsor
Verastem, Inc.
View Trial →
NCT06603844 Phase 1, Phase 2
Recruiting
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Condition
Solid Tumor
Enrollment
156 pts
Location
United States, United Kingdom
Sponsor
Corbus Pharmaceuticals Inc.
View Trial →
NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06263660 Phase 2
Recruiting
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in ...
Condition
Depression
Enrollment
75 pts
Location
United States
Sponsor
Laureate Institute for Brain R
View Trial →
NCT04408430 N/A
Recruiting
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Condition
Mitral Annular Calcification
Enrollment
210 pts
Location
United States, Mexico
Sponsor
Mayra Guerrero
View Trial →
NCT07591428 N/A
Recruiting
Reset Challenge: Reducing High-risk Drinking for Cancer Prevention
Condition
Alcohol Drinking
Enrollment
150 pts
Location
United States
Sponsor
University of Oklahoma
View Trial →
NCT06576271 Phase 1
Recruiting
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE...
Condition
Systemic Lupus Erythematosus
Enrollment
142 pts
Location
United States, Argentina, Brazil
Sponsor
GlaxoSmithKline
View Trial →
NCT05534568 N/A
Recruiting
The Oklahoma Parent-Child Assistance Program
Condition
Substance Use Disorders
Enrollment
200 pts
Location
United States
Sponsor
University of Oklahoma
View Trial →
NCT06059638 N/A
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Condition
Hypertension
Enrollment
316 pts
Location
United States, Australia, Belgium
Sponsor
Orchestra BioMed, Inc
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05849961 N/A
Recruiting
Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)
Condition
Hip Arthroplasty, Total
Enrollment
2,946 pts
Location
United States
Sponsor
Exactech
View Trial →
NCT05256641 Phase 1, Phase 2
Recruiting
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lympho...
Condition
Diffuse Large B-Cell Lymphoma
Enrollment
24 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C
View Trial →
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07209475 Phase 4
Recruiting
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
Condition
Diabetic Foot Ulcer (DFU)
Enrollment
248 pts
Location
United States
Sponsor
Royal Biologics
View Trial →
NCT07500727 N/A
Recruiting
Skeletal Muscle Aging and Responsiveness in Aged People With MS
Condition
Multiple Sclerosis
Enrollment
10 pts
Location
United States
Sponsor
Oklahoma Medical Research Foun
View Trial →
NCT01904851 N/A
Recruiting
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Condition
Peripheral Arterial Disease
Enrollment
14,000 pts
Location
United States
Sponsor
Baylor Research Institute
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05125302 Phase 3
Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets f...
Condition
Migraine
Enrollment
1,059 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT05739981 Phase 1, Phase 2
Recruiting
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnose...
Condition
Ovarian Cancer
Enrollment
30 pts
Location
United States
Sponsor
Imunon
View Trial →
Page 1 of 5 — 110 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology